comparemela.com

Latest Breaking News On - Askgene pharma - Page 1 : comparemela.com

AffaMed Therapeutics Announces First Patient Dosed in the US Phase 1 Clinical Trial of AM712 in Retinal Disease

/PRNewswire/ AffaMed Therapeutics ("AffaMed"), a global clinical-stage biopharmaceutical company dedicated to developing and commercializing transformative.

China
Japan
United-states
Shanghai
Dayao-zhao
Askgene-pharma-inc
Drug-administration
Affamed-therapeutics
Askgene-pharma
Investigational-new-drug
United-states-food
Amed-therapeutics

AffaMed announces dosing of first subject in retinal disease therapy trial

AffaMed Therapeutics has announced dosing of the first subject in the Phase I clinical trial of AM712 to treat retinal diseases in the US.

Japan
Askgene-pharma
Dayao-zhao
Centric-services-for
Contract-manufacturing-organisation
Drug-administration
Time-data-services-for-clinical-research
Affamed-therapeutics
Investigational-new-drug
Centric-services
Alternate-site-clinical-trials
Manufacturing-organisation

AskGene Lands $20 Million in Series A Round - San Fernando Valley Business Journal

AskGene Lands $20 Million in Series A Round - San Fernando Valley Business Journal
sfvbj.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sfvbj.com Daily Mail and Mail on Sunday newspapers.

China
Qiming
Sichuan
Nanjing
Jiangsu
Chinese
Jeff-lu
Askgene-pharma-inc
Askgene-pharma
Qiming-venture-partners

Week In Review: AffaMed Announced US Approval To Start Clinical Trials | FinancialContent Business Page

FinancialContent fully hosted finance channel

Japan
Askgene-pharma

AffaMed Therapeutics Announces IND Clearance by US FDA for AM712 - a Novel Bispecific Biologic for the Treatment of Retinal Vascular Diseases

/PRNewswire/ AffaMed Therapeutics ("AffaMed"), a global clinical stage biotechnology company dedicated to developing and commercializing transformative.

China
Japan
United-states
Shanghai
Ji-li
Dayao-zhao
Jeff-lu
Askgene-pharma-inc
Drug-administration
Amed-therapeutics
United-states-food
Investigational-new-drug

vimarsana © 2020. All Rights Reserved.